Seres Therapeutics, Inc. - Common Stock (MCRB)

Seres Therapeutics is a biotechnology company focused on developing innovative therapeutics that harness the power of the microbiome to treat various diseases, particularly gastrointestinal disorders

The company leverages its proprietary platform to identify and develop next-generation microbiome-based treatments, aiming to restore microbial balance in the human body and improve patient outcomes. Through its research and clinical programs, Seres strives to address unmet medical needs with transformative therapies that have the potential to change the standard of care in multiple therapeutic areas.